Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.5 replaces the previous v3.5.4 on the page. This indicates a minor platform/template update rather than any changes to study data or content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a small metadata update rather than substantive content changes.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov page release rather than changes to the underlying study information.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0. This is a minor maintenance/versioning update that does not affect the study details.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check100 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.